Article Information
History
- February 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Faaiq N Aslam1,
- Tristan A Loveday1,
- Pedro Luiz Serrano Uson Junior2,3,
- Mark Truty7,
- Rory Smoot7,
- Tanios Bekaii-Saab2,
- Daniel Ahn2,
- Mohamad Bassam Sonbol2,
- Christina Wu2,
- Chee-Chee Stucky5,
- Hani Babiker4 and
- Mitesh J Borad2,6,8,*
- 1Alix School of Medicine, Mayo Clinic, Scottsdale, AZ, USA
- 2Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA
- 3Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- 4Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA
- 5Department of Surgery, Mayo Clinic, Phoenix, AZ, USA
- 6Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA
- 7Department of Surgery, Mayo Clinic, Rochester, MN
- 8Mayo Clinic Cancer Center, 5777 E Mayo Blvd, Phoenix, AZ, USA
- ↵*Correspondence: Address to Mitesh J Borad MD, Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, 13400 E Shea Blvd. Scottsdale, AZ 85259. (borad.mitesh{at}mayo.edu)
Posted February 16, 2023.
APRI score is not predictive of post-surgical outcomes in cholangiocarcinoma patients
